Пт, 11/13/2015 - 08:50 — admin
 
 
 

_________________________________________________________

 

We wish you the warmest of greetings to this latest edition of EMJ Oncology. From 25th–29thSeptember, medical professionals and researchers gathered among the medieval alleyways and imperial squares of Vienna, Austria, for a momentous event, ECC 2015. In this eJournal, we have provided a synopsis of the various developments and updates presented there, for your pleasure. Featured in this issue, you will also find a selection of interviews from our venerated editorial board members, as well as an assemblage of abstract and symposium reviews to further pique your interest. Our abstract reviews highlight developments such as a state-of-the-art technique for lymph node biopsy in breast cancer, accompanied by an assessment of research surrounding chimeric antigen receptor T cells targeting childhood cancers.

 
   
 

 

 

 

This year at ECC Congress 2015, research in immunology entered the limelight alongside cancer survivorship, a staple from recent years. Alongside this, advancements in radiology, surgery, and other key aspects of cancer care were presented by some of the brightest minds in the field of oncology. Notable presentations included a study which reported that a cancer diagnosis during pregnancy should no longer be consideration for termination or delay in treatment, and further to this, research that suggests that ovarian function, and indeed fertility, can be preserved by hormone therapy in breast cancer patients. Researchers also highlighted the urgent need, worldwide, for improved access to cancer surgery.

 

 

What's included in this edition of EMJ Oncology?
 

 

 

 

 

 

Congress Review
Review of the European Cancer Congress 2015, held in Vienna, Austria, 
25th–29th September 2015
 
 

Symposium Reviews

 

Article
 
 

Buyer’s Guide

Get Involved
 

 

It is our hope that this eJournal, and the findings presented at ECC 2015, will both serve to enrich clinical practice and treatment around the world and have far-reaching implications for future research. Be sure to also read the March edition of EMJ Oncology, which includes a selection of high quality peer-reviewed manuscripts covering a multitude of oncological topics. To keep updated with the latest news and to stay in touch with EMJ, visit us on our social media platforms: Twitter, Facebook, and YouTube. Finally, we hope that you greatly enjoy this edition of EMJ Oncology, and we wish you all the best for the remainder of the year.

 

 

Warm regards,

 

Zoë Webster

Head of Publishing
 

_________________________________________________________

European Medical Journal 

 

Head Office – The MedBIC, Anglia Ruskin University, Alan Cherry Drive, Chelmsford, Essex, CM1 1SQ 

Sales Office – Coppergate House, 16 Brune Street, London, E1 7NJ

 

Switchboard: +44 (0) 1245 334450 

 

Visit Website

 

Registration No: 08198092. The information contained in this message is confidential and maybe legally privileged. It is intended for the addressee(s) only. Any unauthorised use, dissemination of the information, or unauthorised copying/forwarding of this message is prohibited. If you are not the intended addressee, please notify the sender immediately by return email and delete this message. Any views expressed in this message are those of the individual sender, except where the message states otherwise and the sender is authorised to state them.

_________________________________________________________

 

To ensure that you continue receiving our emails, please add us to your address book or safe list. If you are receiving this email continuously and if you think this is SPAM, please report to circulation@emjreviews.comand we will try our best to resolve your concerns. If you would like to Subscribe, please follow the link at the bottom through to our automated system, alternatively if you would like to Unsubscribe please also use the link provided.